A recent study published in Nature Communications explored the association of COVID-19 with long-term allergic conditions. Study: Incident allergic diseases in post-COVID-19 condition: multinational ...

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...

In the time warp that COVID-19 created in most of our lives, it's hard to believe it's been five years since any of us first heard of a mysterious illness making people sick in China. But it was Dec.

Modern air travel allows infected individuals to move across continents within hours. Diseases that may once have remained ...